Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

The long way to standardization of practices: HbA1c as archetypal example.

Gillery P.

Clin Chem Lab Med. 2018 Nov 22. pii: /j/cclm.ahead-of-print/cclm-2018-1193/cclm-2018-1193.xml. doi: 10.1515/cclm-2018-1193. [Epub ahead of print] No abstract available.

PMID:
30465715
2.

Evaluation of the analytical performances of the Cobas c513 analyser for HbA1c assay.

Jaisson S, Leroy N, Soulard M, Desmons A, Guillard E, Gillery P.

Biochem Med (Zagreb). 2018 Oct 15;28(3):030708. doi: 10.11613/BM.2018.030708.

3.

Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization.

Delatour V, Clouet-Foraison N, Gaie-Levrel F, Marcovina SM, Hoofnagle AN, Kuklenyik Z, Caulfield MP, Otvos JD, Krauss RM, Kulkarni KR, Contois JH, Remaley AT, Vesper HW, Cobbaert CM, Gillery P.

Clin Chem. 2018 Oct;64(10):1485-1495. doi: 10.1373/clinchem.2018.288746. Epub 2018 Aug 7.

PMID:
30087138
4.

Measurement of Homocitrulline, A Carbamylation-derived Product, in Serum and Tissues by LC-MS/MS.

Jaisson S, Desmons A, Doué M, Gorisse L, Pietrement C, Gillery P.

Curr Protoc Protein Sci. 2018 Apr;92(1):e56. doi: 10.1002/cpps.56.

PMID:
30040196
5.

Innovative approaches in diabetes diagnosis and monitoring: less invasive, less expensive… but less, equally or more efficient?

Jaisson S, Gillery P.

Clin Chem Lab Med. 2018 Aug 28;56(9):1397-1399. doi: 10.1515/cclm-2018-0549. No abstract available.

PMID:
29906267
6.

Metrological traceability and harmonization of medical tests: a quantum leap forward is needed to keep pace with globalization and stringent IVD-regulations in the 21st century!

Cobbaert C, Smit N, Gillery P.

Clin Chem Lab Med. 2018 Sep 25;56(10):1598-1602. doi: 10.1515/cclm-2018-0343. No abstract available.

PMID:
29730648
7.

Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers.

Jaisson S, Pietrement C, Gillery P.

Adv Clin Chem. 2018;84:1-38. doi: 10.1016/bs.acc.2017.12.001.

PMID:
29478512
8.

Scientific publishing in the "predatory" era.

Lippi G, Gillery P, Lackner KJ, Melichar B, Payne DA, Schlattmann P, Tate JR, Plebani M.

Clin Chem Lab Med. 2018 Apr 25;56(5):683-684. doi: 10.1515/cclm-2017-1079. No abstract available.

PMID:
29252192
9.

Letter to the Editor regarding "Achieving comparability with IFCC reference method for the measurement of hemoglobin A1c by use of an improved isotope-dilution mass spectrometry method".

Clouet-Foraison N, Gillery P, Delatour V.

Anal Bioanal Chem. 2017 Sep;409(24):5789-5790. doi: 10.1007/s00216-017-0513-5. Epub 2017 Aug 3. No abstract available.

PMID:
28776074
10.

Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA1c measurement.

Desmons A, Jaisson S, Leroy N, Gillery P, Guillard E.

Biochem Med (Zagreb). 2017 Jun 15;27(2):378-386. doi: 10.11613/BM.2017.039.

11.

Carbamylation is a competitor of glycation for protein modification in vivo.

Nicolas C, Jaisson S, Gorisse L, Tessier FJ, Niquet-Léridon C, Jacolot P, Pietrement C, Gillery P.

Diabetes Metab. 2018 Mar;44(2):160-167. doi: 10.1016/j.diabet.2017.05.006. Epub 2017 Jul 8.

PMID:
28690125
12.

Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling.

Clouet-Foraison N, Gaie-Levrel F, Gillery P, Delatour V.

Clin Chem Lab Med. 2017 Aug 28;55(10):1453-1464. doi: 10.1515/cclm-2017-0091. Review.

13.

Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Binder V, Bergum B, Jaisson S, Gillery P, Scavenius C, Spriet E, Nyhaug AK, Roberts HM, Chapple ILC, Hellvard A, Delaleu N, Mydel P.

Thromb Haemost. 2017 May 3;117(5):899-910. doi: 10.1160/TH16-09-0704. Epub 2017 Apr 6.

14.

[Protein molecular aging: which role in physiopathology?]

Jaisson S, Desmons A, Gorisse L, Gillery P.

Med Sci (Paris). 2017 Feb;33(2):176-182. doi: 10.1051/medsci/20173302013. Epub 2017 Feb 27. Review. French.

15.

Absolute Quantification of Bionanoparticles by Electrospray Differential Mobility Analysis: An Application to Lipoprotein Particle Concentration Measurements.

Clouet-Foraison N, Gaie-Levrel F, Coquelin L, Ebrard G, Gillery P, Delatour V.

Anal Chem. 2017 Feb 21;89(4):2242-2249. doi: 10.1021/acs.analchem.6b02909. Epub 2017 Jan 30.

PMID:
28192939
16.

Standardization: Recent achievements of the IFCC Scientific Division.

Gillery P, Young IS.

Clin Chim Acta. 2017 Apr;467:1-3. doi: 10.1016/j.cca.2016.10.024. Epub 2016 Oct 19. No abstract available.

PMID:
27771349
17.

[Protein carbamylation: when protein and chronologic ageings meet].

Gorisse L, Jaisson S, Pietrement C, Gillery P.

Med Sci (Paris). 2016 8-9;32(8-9):684-6. doi: 10.1051/medsci/20163208008. Epub 2016 Sep 12. French. No abstract available.

18.

The Theranos phenomenon, scientific transparency and freedom of speech.

Lackner KJ, Gillery P, Lippi G, Melichar B, Schlattmann P, Tate JR, Plebani M.

Clin Chem Lab Med. 2016 Sep 1;54(9):1403-5. doi: 10.1515/cclm-2016-0520. No abstract available.

19.

The 15th Bergmeyer Conference.

Young IS, Gillery P.

Scand J Clin Lab Invest Suppl. 2016;245:S1. doi: 10.1080/00365513.2016.1206432. Epub 2016 Jul 19. No abstract available.

PMID:
27434757
20.

Homocitrulline as marker of protein carbamylation in hemodialyzed patients.

Jaisson S, Kazes I, Desmons A, Fadel F, Oudart JB, Santos-Weiss IC, Millart H, Touré F, Rieu P, Gillery P.

Clin Chim Acta. 2016 Sep 1;460:5-10. doi: 10.1016/j.cca.2016.06.009. Epub 2016 Jun 11.

PMID:
27302313
21.

Results from external quality assurance (EQA) schemes should be interpreted with caution: A practical example.

Desmons A, Gillery P, Jaisson S.

Clin Chim Acta. 2016 Jul 1;458:49-50. doi: 10.1016/j.cca.2016.04.028. Epub 2016 Apr 23. No abstract available.

PMID:
27118090
22.

Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control.

Jaisson S, Souchon PF, Desmons A, Salmon AS, Delemer B, Gillery P.

J Pediatr. 2016 May;172:56-62. doi: 10.1016/j.jpeds.2016.01.066. Epub 2016 Mar 3.

PMID:
26947567
23.

Protein carbamylation is a hallmark of aging.

Gorisse L, Pietrement C, Vuiblet V, Schmelzer CE, Köhler M, Duca L, Debelle L, Fornès P, Jaisson S, Gillery P.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1191-6. doi: 10.1073/pnas.1517096113. Epub 2015 Dec 28.

24.

Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes.

Hocine A, Belmokhtar K, Bauley K, Jaisson S, Gaha K, Oubaya N, Lesaffre F, Lavaud S, Halin P, Gillery P, Rieu P, Touré F.

Perit Dial Int. 2015 Sep-Oct;35(5):592-4. doi: 10.3747/pdi.2013.00338. No abstract available.

25.

Homocitrulline: a new marker for differentiating acute from chronic renal failure.

Desmons A, Jaisson S, Pietrement C, Rieu P, Wynckel A, Gillery P.

Clin Chem Lab Med. 2016 Jan;54(1):73-9. doi: 10.1515/cclm-2015-0398.

PMID:
26124058
26.

New trends in the long and puzzling history of HbA1c.

Gillery P.

Clin Chem Lab Med. 2015 Aug;53(9):1297-9. doi: 10.1515/cclm-2015-0413. No abstract available.

27.

Analytical performances of the D-100TM hemoglobin testing system (Bio-Rad) for HbA1c assay.

Jaisson S, Leroy N, Guillard E, Desmons A, Gillery P.

Clin Chem Lab Med. 2015 Aug;53(9):1473-9. doi: 10.1515/cclm-2015-0288.

PMID:
26011926
28.

[Role of protein carbamylation in chronic kidney disease complications].

Gillery P, Jaisson S, Gorisse L, Pietrement C.

Nephrol Ther. 2015 Jun;11(3):129-34. doi: 10.1016/j.nephro.2014.12.004. Epub 2015 Mar 17. French.

PMID:
25794932
29.

Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics.

Weykamp C, John G, Gillery P, English E, Ji L, Lenters-Westra E, Little RR, Roglic G, Sacks DB, Takei I; IFCC Task Force on Implementation of HbA1c Standardization.

Clin Chem. 2015 May;61(5):752-9. doi: 10.1373/clinchem.2014.235333. Epub 2015 Mar 3.

30.

[Assays of HbA1c and Amadori products in human biology].

Gillery P.

Ann Pharm Fr. 2014 Sep;72(5):330-6. doi: 10.1016/j.pharma.2014.04.002. Epub 2014 May 6. Review. French.

PMID:
25220229
31.

Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease.

Jaisson S, Kerkeni M, Santos-Weiss IC, Addad F, Hammami M, Gillery P.

Clin Chem Lab Med. 2015 Jan;53(1):103-10. doi: 10.1515/cclm-2014-0642.

PMID:
25153409
32.

Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.

Kerkeni M, Weiss IS, Jaisson S, Dandana A, Addad F, Gillery P, Hammami M.

Thromb Res. 2014 Sep;134(3):633-8. doi: 10.1016/j.thromres.2014.07.008. Epub 2014 Jul 17.

PMID:
25065554
33.

Diagnosis of diabetes mellitus: reiterated responsibilities for the clinical laboratory.

Gillery P, Lippi G, Plebani M.

Clin Chem Lab Med. 2014 Jul;52(7):935-6. doi: 10.1515/cclm-2014-0443. No abstract available.

34.

Impaired proteostasis: role in the pathogenesis of diabetes mellitus.

Jaisson S, Gillery P.

Diabetologia. 2014 Aug;57(8):1517-27. doi: 10.1007/s00125-014-3257-1. Epub 2014 May 11. Review.

PMID:
24816368
35.

Analytical performances of a new enzymatic assay for hemoglobin A1c.

Jaisson S, Desmons A, Renard B, Chevelle B, Leroy N, Gillery P.

Clin Chim Acta. 2014 Jul 1;434:48-52. doi: 10.1016/j.cca.2014.04.008. Epub 2014 Apr 24.

PMID:
24768786
36.

Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.

Aubert CE, Michel PL, Gillery P, Jaisson S, Fonfrede M, Morel F, Hartemann A, Bourron O.

Diabetes Metab Res Rev. 2014 Nov;30(8):679-85. doi: 10.1002/dmrr.2529.

PMID:
24449227
37.

Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD.

Pietrement C, Gorisse L, Jaisson S, Gillery P.

PLoS One. 2013 Dec 4;8(12):e82506. doi: 10.1371/journal.pone.0082506. eCollection 2013.

38.

[Interest of the study of a not identified peak on a hemoglobin chromatogram: delta variant or inter-sample contaminations?].

Desmons A, Jaisson S, Gillery P, Guillard E.

Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):577-80. doi: 10.1684/abc.2013.0867. French.

39.

Detection of unknown β-thalassemia cases from atypical HbA1c chromatograms.

Desmons A, Guillard E, Jaisson S, Gillery P.

Clin Chem Lab Med. 2013 Dec;51(12):e301-3. doi: 10.1515/cclm-2013-0364. No abstract available.

PMID:
23969468
40.

Frontiers in research on the Maillard reaction in aging and chronic disease.

Baynes JW, Gillery P.

Clin Chem Lab Med. 2014 Jan 1;52(1):1-3. doi: 10.1515/cclm-2013-0551. No abstract available.

41.

Interference of the most frequent haemoglobin variants on quantification of HbA1c: comparison between the LC-MS (IFCC reference method) and three routinely used methods.

Jaisson S, Leroy N, Desroches C, Tonye-Libyh M, Guillard E, Gillery P.

Diabetes Metab. 2013 Sep;39(4):363-9. doi: 10.1016/j.diabet.2013.01.004. Epub 2013 Apr 29.

PMID:
23639569
42.

Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseases.

Gillery P, Jaisson S.

J Proteomics. 2013 Oct 30;92:228-38. doi: 10.1016/j.jprot.2013.02.015. Epub 2013 Feb 28. Review.

PMID:
23459210
43.

Post-translational modification derived products (PTMDPs): toxins in chronic diseases?

Gillery P, Jaisson S.

Clin Chem Lab Med. 2014 Jan 1;52(1):33-8. doi: 10.1515/cclm-2012-0880. Review.

PMID:
23454717
44.

Progress towards standardization: an IFCC Scientific Division Perspective.

Gillery P, Young IS; IFCC Scientific Division.

Clin Chem Lab Med. 2013 May;51(5):915-8. doi: 10.1515/cclm-2013-0081. No abstract available.

PMID:
23435099
45.

A young adult with sarcosinemia. No benefit from long duration treatment with memantine.

Benarrosh A, Garnotel R, Henry A, Arndt C, Gillery P, Motte J, Bakchine S.

JIMD Rep. 2013;9:93-96. doi: 10.1007/8904_2012_185. Epub 2012 Oct 21.

46.

Glucose meters - fit for clinical purpose.

Tirimacco R, Koumantakis G, Erasmus R, Mosca A, Sandberg S, Watson ID, Goldsmith B, Gillery P; International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Glucose Point-of-Care Testing.

Clin Chem Lab Med. 2013 May;51(5):943-52. doi: 10.1515/cclm-2013-0011. Review.

PMID:
23399591
47.

[Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods].

Schneider N, Wynckel A, Kolb B, Sablon E, Gillery P, Maquart FX.

Ann Biol Clin (Paris). 2013 Jan-Feb;71(1):13-9. doi: 10.1684/abc.2012.0785. French.

48.

The plasma logarithm of the triglyceride/HDL-cholesterol ratio is a predictor of low risk gestational diabetes in early pregnancy.

dos Santos-Weiss IC, Réa RR, Fadel-Picheth CM, Rego FG, Pedrosa Fde O, Gillery P, Souza EM, Picheth G.

Clin Chim Acta. 2013 Mar 15;418:1-4. doi: 10.1016/j.cca.2012.12.004. Epub 2012 Dec 20.

PMID:
23262368
49.

Glycemic control in the clinical management of diabetic patients.

Mosca A, Lapolla A, Gillery P.

Clin Chem Lab Med. 2013 Apr;51(4):753-66. doi: 10.1515/cclm-2012-0594.

PMID:
23241605
50.

Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal.

Lippi G, Gillery P, Kazmierczak S, Lackner KJ, Melichar B, Siest G, Whitfield JB, Jahnke H, Plebani M.

Clin Chem Lab Med. 2013 Jan;51(1):5-7. doi: 10.1515/cclm-2012-0449. No abstract available.

PMID:
23093279

Supplemental Content

Loading ...
Support Center